Topiramate
NDC 70710-1042, Topiramate, capsule, extended release, from Zydus Pharmaceuticals USA Inc..
- Product NDC
- 70710-1042
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208949
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1042 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOPIRAMATE150 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70710-1042-3 | 70710104203 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70710-1042-3) |
| 70710-1042-9 | 70710104209 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70710-1042-9) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/a5ca2fce-bd2d-40db-b963-e3ec27c8bf23NADAC price for package 70710104203
GET /v1/drugs/nadac/70710104203
Use it
Look up 70710-1042 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1042 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70710-1042. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.